Development and Evaluation of Two Potential 5-HT7 Receptor PET Tracers: [18F]ENL09 and [18F]ENL10

Elina Tampio L'Estrade, Mengfei Xiong, Vladimir Shalgunov, Fraser G. Edgar, Balázs Volk, Simone L. Baerentzen, Mikael Palner, Maria Erlandsson, Tomas Ohlsson, Gitte M. Knudsen, Matthias M. Herth*

*Corresponding author for this work
3 Citations (Scopus)

Abstract

The latest addition to the serotonin (5-HT) receptor family is the 5-HT7 receptor (5-HT7R). This receptor has gained interest as a drug target due to its involvement in various disorders such as depression or schizophrenia. There is currently no clinically validated positron emission tomography (PET) tracer for the 5-HT7R available. But, the (arylpiperazinyl-butyl)oxindole scaffold provides a promising lead structure for this purpose. Here, we synthesized 12 (arylpiperazinyl-butyl)oxindole derivatives and in vitro affinity screening identified two structures with suitable affinity and selectivity to be radiolabeled and tested as 5-HT7R selective PET tracers. Next, the radiolabeled products [18F]ENL09 and [18F]ENL10 were evaluated as PET tracers in rats. Both tracers were found to be P-gp substrates, but after P-gp inhibition the brain uptake showed a regional distribution in line with the known 5-HT7R distribution.  The [18F]ENL10 brain binding was displaceable with a 5-HT7R selective ligand, whereas [18F]ENL09 was not. We find that [18F]ENL10 is a promising 5-HT7R selective PET tracer candidate that should be investigated in higher species.
Original languageEnglish
JournalACS Chemical Neuroscience
Volume10
Issue number9
Pages (from-to)3961-3968
Number of pages8
ISSN1948-7193
DOIs
Publication statusPublished - 18 Sept 2019

Keywords

  • 5-HT R
  • fluorine-18
  • fragment-based dual-labeling
  • PDSP
  • PET
  • rat

Fingerprint

Dive into the research topics of 'Development and Evaluation of Two Potential 5-HT7 Receptor PET Tracers: [18F]ENL09 and [18F]ENL10'. Together they form a unique fingerprint.

Cite this